• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肢端肥大症的当前诊断与治疗]

[Current diagnosis and treatment of acromegaly].

作者信息

Melgar Virgilio, Espinosa Etual, Cuenca Dalia, Valle Vanessa, Mercado Moisés

机构信息

Servicio de Endocrinología, Unidad de Investigación Médica en Endocrinología Experimental, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Distrito Federal, México.

出版信息

Rev Med Inst Mex Seguro Soc. 2015 Jan-Feb;53(1):74-83.

PMID:25680646
Abstract

Acromegaly is a rare condition characterized by the excessive secretion of growth hormone (GH), usually by a pituitary adenoma. The clinical manifestations of acromegaly include enlarged hands, feet and face, headaches, arthralgias, fatigue and hyperhydrosis. This condition is also associated with comorbidities such as hypertension and diabetes in a significant proportion of patients and frequently compromises life quality and life expectancy. The biochemical diagnosis of acromegaly rests on the demonstration of an autonomous secretion of GH by means of the measurement of glucose-suppressed GH levels and the serum concentration of insulin like growth factor type 1 (IGF-1). The localizing method of choice is magnetic resonance image of the selar area, which in 70 % of the cases reveals the presence of a macroadenoma. Even though the primary treatment is usually the transsphenoidal resection of the adenoma, the majority of patients require a multimodal intervention that includes radiotherapy, as well as pharmacological therapy with somatostatin analogs and dopamine agonists. The latter approach has resulted in a significant reduction in mortality and in an improvement in the quality of life.

摘要

肢端肥大症是一种罕见病症,其特征是生长激素(GH)分泌过多,通常由垂体腺瘤引起。肢端肥大症的临床表现包括手足和面部增大、头痛、关节痛、疲劳和多汗。在相当一部分患者中,这种病症还与高血压和糖尿病等合并症相关,并且常常影响生活质量和预期寿命。肢端肥大症的生化诊断依赖于通过测量葡萄糖抑制后的GH水平和血清1型胰岛素样生长因子(IGF-1)浓度来证明GH的自主分泌。首选的定位方法是蝶鞍区磁共振成像,70%的病例中可显示存在大腺瘤。尽管主要治疗通常是经蝶窦切除腺瘤,但大多数患者需要多模式干预,包括放疗以及使用生长抑素类似物和多巴胺激动剂进行药物治疗。后一种方法已使死亡率显著降低,并改善了生活质量。

相似文献

1
[Current diagnosis and treatment of acromegaly].[肢端肥大症的当前诊断与治疗]
Rev Med Inst Mex Seguro Soc. 2015 Jan-Feb;53(1):74-83.
2
Acromegaly.肢端肥大症
Pituitary. 2006;9(4):297-303. doi: 10.1007/s11102-006-0409-4.
3
Pituitary tumours: acromegaly.垂体肿瘤:肢端肥大症。
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):555-74. doi: 10.1016/j.beem.2009.05.010.
4
Acromegaly.肢端肥大症
Handb Clin Neurol. 2014;124:197-219. doi: 10.1016/B978-0-444-59602-4.00014-9.
5
[Advances in the treatment of acromegaly].[肢端肥大症的治疗进展]
Pol Merkur Lekarski. 2008 Jan;24(139):59-65.
6
LIMITATIONS OF CURRENT APPROACHES FOR THE TREATMENT OF ACROMEGALY.当前肢端肥大症治疗方法的局限性
Endocr Pract. 2016 Feb;22(2):210-9. doi: 10.4158/EP15825.RA. Epub 2015 Oct 5.
7
Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.在罗马尼亚一家三级护理中心,接受生长抑素类似物治疗的肢端肥大症患者中,剂量递增和手术减瘤的有益效果。
Hormones (Athens). 2016 Apr;15(2):224-234. doi: 10.14310/horm.2002.1675.
8
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.分泌生长激素释放激素的神经内分泌肿瘤:病理生理与临床方面
Pituitary. 2006;9(3):221-9. doi: 10.1007/s11102-006-0267-0.
9
Acromegaly, a pituitary special issue.肢端肥大症,垂体专题。
Pituitary. 2017 Feb;20(1):2-3. doi: 10.1007/s11102-017-0790-1.
10
A registry of acromegaly patients and one year following up in Taiwan.台湾肢端肥大症患者登记及一年随访。
J Formos Med Assoc. 2019 Oct;118(10):1430-1437. doi: 10.1016/j.jfma.2018.12.017. Epub 2019 Jan 4.

引用本文的文献

1
Echocardiographic Findings in Cardiomyopathy Due to Acromegaly.肢端肥大症所致心肌病的超声心动图表现
Biomedicines. 2025 Mar 1;13(3):605. doi: 10.3390/biomedicines13030605.